Clinical lymphoma, myeloma & leukemia
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma.
Paula Rodríguez-Otero, Philippe Moreau, Maria Victoria Mateos, Maria Theresa Krauth, Leo Rasche, Efstathios Kastritis, Albert Oriol, Elena Zamagni, Claire Albrecht, Eva Rubio-Azpeitia, Niels W C J van de Donk
Published: 202510.1016/j.clml.2025.12.003
Abstract
The global incidence of multiple myeloma (MM) continues to rise. While survival rates for newly diagnosed patients have improved substantially with the introduction of novel therapies, outcomes remain poor for those with triple-class-exposed (TCE) re…
Preview only. Read the full abstract at the source